SAMSUNG BIOEPIS CO., LTD.

AMELIVU

Pharmaceutical preparations for treating neovascular age-related macular degeneration; pharmaceutical preparations for treating diabetic macular edema; pharmaceutical preparations for the treatment of angiogenesis diseases and disorders; eye drops; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for ocular or intraocular surgery; ocular pharmaceuticals; ophthalmic preparations; pharmaceutical preparations for treating diabetes; human vaccine preparations; preparations for medical use, namely, preparations, biological formulations, biological preparations, antibody formulations and protein formulations, for immunoregulation and for the treatment of immunologic disorders, autoimmune diseases, inflammatory diseases, arthritis, cancer, tumor, central nervous system disorders and metabolic diseases; pharmaceutical preparations for the treatment of inflammatory diseases; antidiabetic preparations; pharmaceutical preparations for the treatment of metabolic diseases and disorders; pharmaceutical preparations for the prevention of ocular disorders or diseases; cardiovascular agents for medical purposes; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; dietary supplements;

BECILICA

Pharmaceutical preparations for the treatment of oncological diseases and disorders; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of autoimmune diseases and disorders; Pharmaceutical preparations for the treatment of metabolic diseases and disorders; Pharmaceutical preparations for the treatment of inflammatory diseases and disorders; Pharmaceutical preparations for the treatment of damaged skin and tissue; Ophthalmic preparations; Ocular pharmaceuticals;

BECIZANT

Pharmaceutical preparations for the treatment of oncological diseases and disorders; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of autoimmune diseases and disorders; Pharmaceutical preparations for the treatment of metabolic diseases and disorders; Pharmaceutical preparations for the treatment of inflammatory diseases and disorders; Pharmaceutical preparations for the treatment of damaged skin and tissue; Ophthalmic preparations; Ocular pharmaceuticals;

BEVATIO

Pharmaceutical preparations for the treatment of oncological diseases and disorders; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of autoimmune diseases and disorders; Pharmaceutical preparations for the treatment of metabolic diseases and disorders; Pharmaceutical preparations for the treatment of inflammatory diseases and disorders; Pharmaceutical preparations for the treatment of damaged skin and tissue; Ophthalmic preparations; Ocular pharmaceuticals;

BIOEPIS

In the statement, Page 1, line 1, LTD should be deleted, and LTD. should be inserted.;Preparations for medical use, namely, preparations, biological formulations, biological preparations, antibody formulations and protein formulations for treatment of immunologic disorders, for immunoregulation, for treatment of autoimmune diseases, for treatment of inflammatory diseases, for treatment of arthritis, for Anti-cancer agents, for treatment of cancer, for treatment of tumor, for treatment of central nervous system disorders and for treatment of metabolic diseases; Preparations for treatment of immunologic disorders; Preparations for immunoregulation; Preparations for treatment of autoimmune diseases; Preparations for treatment of inflammatory diseases; Preparations for treatment of arthritis; Anti-cancer agents; Preparations for treatment of cancer; Preparations for treatment of tumor; Preparations for diagnosis for medical purposes; Preparations for treatment of central nervous system disorders; Preparations for treatment of metabolic diseases; Biological tissue cultures for medical purposes;Pharmaceutical research and development; Bacteriological research; Biological research; Biotechnology research; Biopharmaceutical research and development; Medical product testing; Research and development for new products for others; Material testing; Chemistry services, namely, chemistry consultation; Chemical research and analysis; Biotechnology consultation; Pharmaceutical development using animal cells; Scientific technology research relating to plant genetics; Laboratory equipment rental;

BIOEPIS

The mark consists of the stylized wording BIOEPSIS wherein the letter B is in orange, the letter I is in pink, the letter O is in green and the letters EPIS appear in purple. The color white represents transparent background and is not claimed as a feature of the mark.;Preparations for medical use, namely, preparations, biological formulations, biological preparations, antibody formulations and protein formulations for treatment of immunologic disorders, for immunoregulation, for treatment of autoimmune diseases, for treatment of inflammatory diseases, for treatment of arthritis, for Anti-cancer agents, for treatment of cancer, for treatment of tumor, for treatment of central nervous system disorders and for treatment of metabolic diseases; Preparations for treatment of immunologic disorders; Preparations for immunoregulation; Preparations for treatment of autoimmune diseases; Preparations for treatment of inflammatory diseases; Preparations for treatment of arthritis; Anti-cancer agents; Preparations for treatment of cancer; Preparations for treatment of tumor; Preparations for diagnosis for medical purposes; Preparations for treatment of central nervous system disorders; Preparations for treatment of metabolic diseases; Biological tissue cultures for medical purposes;The color(s) orange, pink, green and purple is/are claimed as a feature of the mark.;Pharmaceutical research and development; Bacteriological research; Biological research; Biotechnology research; Biopharmaceutical research and development; Medical product testing; Research and development for new products for others; Material testing; Chemistry services, namely, chemistry consultation; Chemical research and analysis; Biotechnology consultation; Pharmaceutical development using animal cells; Scientific technology research relating to plant genetics; Laboratory equipment rental;